DE69124875D1 - Verwendung des L-Deprenyls zur Verzögerung der altersbedingten Zerstörung des Gedächtnis bei Hunden - Google Patents

Verwendung des L-Deprenyls zur Verzögerung der altersbedingten Zerstörung des Gedächtnis bei Hunden

Info

Publication number
DE69124875D1
DE69124875D1 DE69124875T DE69124875T DE69124875D1 DE 69124875 D1 DE69124875 D1 DE 69124875D1 DE 69124875 T DE69124875 T DE 69124875T DE 69124875 T DE69124875 T DE 69124875T DE 69124875 D1 DE69124875 D1 DE 69124875D1
Authority
DE
Germany
Prior art keywords
deprenyl
dogs
memory loss
related memory
delay age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69124875T
Other languages
English (en)
Other versions
DE69124875T2 (de
Inventor
Norton W Milgram
David R Stevens
Gwendolyn O Ivy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deprenyl Animal Health Inc
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69124875(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of DE69124875D1 publication Critical patent/DE69124875D1/de
Publication of DE69124875T2 publication Critical patent/DE69124875T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thin Film Transistor (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
  • Pulse Circuits (AREA)
DE69124875T 1990-08-31 1991-03-28 Verwendung des L-Deprenyls zur Verzögerung der altersbedingten Zerstörung des Gedächtnis bei Hunden Expired - Fee Related DE69124875T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (2)

Publication Number Publication Date
DE69124875D1 true DE69124875D1 (de) 1997-04-10
DE69124875T2 DE69124875T2 (de) 1997-06-26

Family

ID=27076843

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69124875T Expired - Fee Related DE69124875T2 (de) 1990-08-31 1991-03-28 Verwendung des L-Deprenyls zur Verzögerung der altersbedingten Zerstörung des Gedächtnis bei Hunden
DE69131386T Revoked DE69131386T2 (de) 1990-08-31 1991-03-28 Verwendung von L-Deprenyl zur Hemmung des Alterniedergangs des Immunsystems in Säugetieren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69131386T Revoked DE69131386T2 (de) 1990-08-31 1991-03-28 Verwendung von L-Deprenyl zur Hemmung des Alterniedergangs des Immunsystems in Säugetieren

Country Status (16)

Country Link
US (2) US5276057A (de)
EP (2) EP0732101B1 (de)
JP (3) JP2819072B2 (de)
AT (2) ATE181501T1 (de)
AU (1) AU633714B2 (de)
BR (1) BR9103506A (de)
CA (1) CA2039194C (de)
DE (2) DE69124875T2 (de)
DK (2) DK0732101T3 (de)
ES (2) ES2135123T3 (de)
GR (2) GR3022971T3 (de)
HK (1) HK1011611A1 (de)
ID (1) ID19492A (de)
MX (1) MX9100067A (de)
MY (2) MY110217A (de)
NZ (1) NZ238277A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
JPH06506204A (ja) * 1991-04-04 1994-07-14 ザ・ユニバーシティ・オブ・トロント・イノベイションズ・ファウンデイション 神経細胞機能を維持し、喪失を防止し、または回復させるためのデプレニールの使用
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
PT623344E (pt) * 1993-05-04 2000-12-29 Ceva Sante Animale Utilizacao da selegilina em medicina veterinaria
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
WO1996022068A2 (en) 1995-01-13 1996-07-25 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
AU723047B2 (en) * 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
WO1996040085A2 (en) 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DK0866691T4 (da) * 1995-11-06 2005-06-06 Somerset Pharmaceuticals Inc Medikamenter til sublingual og bukkal administration af selegilin
IL138290A0 (en) 1998-03-16 2001-10-31 Somerset Pharmaceuticals Inc Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
US8058442B2 (en) * 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
CA2523567A1 (en) * 2003-04-25 2004-11-11 Indevus Pharmaceuticals, Inc. Method for promoting uninterrupted sleep by administration of trospium chloride
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
CA2547053C (en) 2003-11-25 2014-05-27 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
JP2013515781A (ja) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物のためのピルベートを含む組成物、およびその使用法
CN102791258B (zh) 2010-02-03 2018-05-08 图必制药公司 雷沙吉兰的延长释放制剂及其用途
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
GR3022971T3 (en) 1997-06-30
EP0732101B1 (de) 1999-06-23
EP0473252A3 (en) 1992-08-05
US5387615A (en) 1995-02-07
ES2135123T3 (es) 1999-10-16
CA2039194C (en) 1997-01-28
MX9100067A (es) 1992-04-01
CA2039194A1 (en) 1992-03-01
DK0473252T3 (da) 1997-09-15
EP0732101A1 (de) 1996-09-18
JP2819072B2 (ja) 1998-10-30
DE69131386D1 (de) 1999-07-29
JPH09328422A (ja) 1997-12-22
BR9103506A (pt) 1992-05-12
DE69124875T2 (de) 1997-06-26
MY124210A (en) 2006-06-30
ATE149350T1 (de) 1997-03-15
JP2884501B2 (ja) 1999-04-19
GR3031263T3 (en) 1999-12-31
AU633714B2 (en) 1993-02-04
EP0473252B1 (de) 1997-03-05
DE69131386T2 (de) 1999-11-25
AU7395791A (en) 1992-03-05
ID19492A (id) 1998-07-16
EP0473252A2 (de) 1992-03-04
JPH09328423A (ja) 1997-12-22
JP2884500B2 (ja) 1999-04-19
US5276057A (en) 1994-01-04
NZ238277A (en) 1993-10-26
ES2097790T3 (es) 1997-04-16
ATE181501T1 (de) 1999-07-15
JPH04230624A (ja) 1992-08-19
HK1011611A1 (en) 1999-07-16
DK0732101T3 (da) 1999-11-22
MY110217A (en) 1998-03-31

Similar Documents

Publication Publication Date Title
DE69124875T2 (de) Verwendung des L-Deprenyls zur Verzögerung der altersbedingten Zerstörung des Gedächtnis bei Hunden
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
NO881102D0 (no) Innhegning i sjoeen for fiskeoppdrett.
DK521589A (da) Cyclopropyl-substituerede dialkyl-forbindelser med insekticid virkning
SE503436C2 (sv) Pyroglutamidderivat
DE3881533D1 (de) Tiermedizinische zusammensetzung zur verhinderung von diarrhoe bei tieren.
DE3851456T2 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
FI881420A (fi) Voimalaitos, jossa palaminen tapahtuu leijukerroksessa
DE59103571D1 (de) Synergistische Mittel zur Regulierung des Pflanzenwachstums.
DE69207898D1 (de) Wirkstoff zur hautbehandlung bei tieren
KR880021088U (ko) 양어장용 공기 분사기
ES556049A0 (es) Instalacion para la cria de conejos y de animales similares
KR880021073U (ko) 애완용 동물 침구
IT8848093A0 (it) Composizioni atte ad aumentare la crescita di animali e composti in esse contenuti
BR6602122U (pt) Ferradura amortecedora e antiderrapante para cavalos
ES294387Y (es) Herradura de caucho para caballerias
NO871971D0 (no) Anordning for kontroll av foring i fiskeoppdrettsanlegg.
KR890015797U (ko) 사육동물 분만용 산실기
ITRA910008V0 (it) Distributopre semovente di mangime, pellettato di sfuso, per l'ali- mentazione di animali in batteria
KR910017900U (ko) 로울러스케이트의 축수부
KR880015550U (ko) 병아리 사육기

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee